The effects of onabotulinum toxin A injection into rectus femoris muscle in hemiplegic stroke patients with stiff-knee gait: A placebo-controlled, nonrandomized trial

American Journal of Physical Medicine and Rehabilitation

Volumn 91, Issue 4, 2012, Pages 321-326

  Tok, Fatih ^a   Balaban, Birol ^b   Yaşar, Evren ^b   Alaca, Rdvan ^b   Tan, Arif Kenan ^b  

^a Iskenderun Military Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Botulinum Toxin Type A; Rectus Femoris; Stiff Knee Gait; Stroke; Three Dimensional Gait Analysis

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; FEMALE; FOLLOW UP; HEMIPLEGIA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE; RISK ASSESSMENT; SPASTICITY; STROKE; TREATMENT OUTCOME;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; GAIT DISORDERS, NEUROLOGIC; HEMIPLEGIA; HUMANS; INJECTIONS, INTRAMUSCULAR; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE SPASTICITY; QUADRICEPS MUSCLE; RANGE OF MOTION, ARTICULAR; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

EID: 84859104903     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3182465feb     Document Type: Article

References (24)

1. Bleyenheuft C, Cockx S, Caty G, et al: The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait. Gait Posture 2009;30:168-72
2. Robertson JV, Pradon D, Bensmail D, et al: Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait Posture 2009;29:108-12
3. Caty GD, Detrembleur C, Bleyenheuft C, et al: Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke 2008;39:2803-8
4. Stoquart GG, Detrembleur C, Palumbo S, et al: Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: A prospective observational study. Arch Phys Med Rehabil 2008;89: 56-61 (Pubitemid 350299008)
5. Kerrigan DC, Karvosky ME, Riley PO: Spastic paretic stiff-legged gait: Joint kinetics. Am J Phys Med Rehabil 2001;80:244-9 (Pubitemid 32240192)
6. Riley PO, Kerrigan DC: Torque action of two-joint muscles in the swing period of stiff-legged gait: A forward dynamic model analysis. J Biomech 1998;31: 835-40 (Pubitemid 28474686)
7. Miller F, Cardoso Dias R, Lipton GE, et al: The effect of rectus EMG patterns on the outcome of rectus femoris transfers. J Pediatr Orthop 1997;17:603-7 (Pubitemid 28048743)
8. Chambers H, Lauer A, Kaufman K, et al: Prediction of outcome after rectus femoris surgery in cerebral palsy: The role of cocontraction of the rectus femoris and vastus lateralis. J Pediatr Orthop 1998;18: 703-11 (Pubitemid 28506813)
9. Pittock SJ, Moore AP, Hardiman O, et al: A doubleblind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 2003;15:289-300 (Pubitemid 36438734)
10. Mancini F, Sandrini G, Moglia A, et al: A randomised, doubleblind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci 2005;26:26-31 (Pubitemid 40723938)
11. Turkel CC, Bowen B, Liu J, et al: Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil 2006;87:786-92 (Pubitemid 43767710)
12. Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7 (Pubitemid 17026064)
13. Wade DT, Wood VA, Heller A: Walking after stroke. Scand J Rehabil Med 1987;19:25-30
14. Kosak M, Smith T: Comparison of the 2-, 6-, and 12- minute walk tests in patients with stroke. J Rehabil Res Dev 2005;42:103-8 (Pubitemid 40464162)
15. Davis RB III, Ounpuu S, Tyburski D, et al: A gait analysis data collection and reduction technique. Hum Mov Sci 1991;10:575-87
16. Unnithan VB, Dowling JJ, Frost G, et al: Role of cocontraction in the O2 cost of walking in children with cerebral palsy. Med Sci Sports Exerc 1996;28: 1498-504 (Pubitemid 26424674)
17. Borg J, Ward AB, Wissel J, et al: BEST Study Group: Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: Evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. J Rehabil Med 2011;43:15-22
18. Kaji R, Osako Y, Suyama K, et al: GSK1358820
19. Spasticity Study Group: Botulinum toxin type A in post-stroke lower limb spasticity: A multicenter, doubleblind, placebo-controlled trial. J Neurol 2010;257: 1330-7
20. Chang CL, Munin MC, Skidmore ER, et al: Effect of baseline spastic hemiparesis on recovery of upperlimb function following botulinum toxin type A injections and postinjection therapy. Arch Phys Med Rehabil 2009;90:1462-8
21. Elia AE, Filippini G, Calandrella D, et al: Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. Mov Disord 2009;24:801-12
22. Collen FM, Wade DT, Bradshaw CM: Mobility after stroke: Reliability of measures of impairment and disability. Int Disabil Stud 1990;12:6-9 (Pubitemid 20300158)
23. Holden MK, Gill KM, Magliozzi MR, et al: Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther 1984;64:35-40
24. Friedman PJ: Gait recovery after hemiplegic stroke. Int Disabil Stud 1990;12:119-22